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is recognized as a separate condition next to EFAD, but isolated ω6-deficiency in humans is probably rare. Among the clinical features of EFAD and isolated ω3-deficiency are impaired growth, skin lesions, infertility, kidney abnormalities, fatty liver, polydipsia, increased susceptibility to infections, reduced learning and impaired vision [1] [2] [3] [4] . These symptoms are nonspecific and may develop after long standing marginal EFA status [5] . Therefore, present clinical chemical cut-off values for EFAD and isolated ω3-deficiency are mostly based on the detection of disbalances between the ω3, ω6, ω7, ω9 and saturated FA families [6] . Such cut-off values do not necessarily relate to the presence of clinically detectable symptoms or disease development as gold standards, and a biochemical deficiency is therefore not to be confused with a clinically detectable deficiency.
The parent EFA linoleic (18:2ω6) and α-linolenic (18:3ω3) acids, and their long-chain polyunsaturated FA homologues of the ω3 and ω6 series (LCP; ≥C20 with at least 3 double bonds in methylene interrupted cis-configuration) are structural elements of membrane phospholipids and precursors of hydroxy FA and eicosanoids via the lipoxygenase and cyclooxygenase pathways [1, 6] . Parent EFA derive exclusively from the diet, whereas LCP derive either from the diet or synthesis from parent EFA. Important food sources are vegetable oils like sunflower (18:2ω6) or soybean (18:2ω6 and 18:3ω3) oils, meat (arachidonic acid, 20:4ω6) and fish (eicosapentaenoic acid, 20:5ω3 and docosahexaenoic acid, 22:6ω3). LCP synthesis from 18:2ω6 and 18:3ω3 occurs by desaturation, chainelongation and chain-shortening, with ∆6-desaturation as the first and rate-limiting step. Both 18:2ω6 (to 20:4ω6) and 18:3ω3 (to 22:6ω3 via 20:5ω3), but also non-essential oleic acid (18:1ω9) compete for conversion by ∆6-desaturase. This enzyme has preference for its substrates in the order 18:3ω3>18:2ω6>18:1ω9, implying that some combination of low 18:3ω3 and 18:2ω6 status is needed to allow 18:1ω9 to serve as a ∆6-desaturase substrate for the formation of 20:3ω9 (also known as 'Mead acid') and 22:3ω9. Mead acid incorporation into tissue lipids is associated with platelet hyperactivity [7] , vasoconstriction [8] and altered cell-cell adhesion [9] but its feeding to rats has no adverse effects on health or growth [10] .
Both 20:3ω9 and the so-called triene-tetraene (20:3ω9/20:4ω6) ratio are widely used as markers for biochemical EFAD [6, 11, 12] . The total plasma 20:3ω9/20:4ω6 ratio has for many years been the EFAD 'gold standard'. With time, the upper-limit has been reduced from 0.4 to 0.2 [13] . Mead acid increases prior to a 20:4ω6 decrease, since tissues and notably brain [6] tend to conserve 20:4ω6 at developing EFA deficiency [10, 14] . Total plasma may also not be the preferred compartment, since its FA profile derives from at least four different lipid classes, which are located in a variety of lipoproteins with different functions, origins, targets, turnover rates and interindividual compositions. Erythrocyte (RBC) FA contents might provide a more reliable parameter of cellular EFA-status, which reflects bone marrow FA availability and plasma-RBC phospholipid exchange processes of the preceding 2-3 months. RBC FA derive solely from RBC plasma membrane phospholipids, contain the full range of LCP, are well defined with respect to their dietary dependence [6] and relate to the FA composition of brain [15, 16] . RBC FA might on the other hand be somewhat dependent on RBC age-distribution [17] .
Isolated ω3-deficiency has attracted attention since its recognition in a 6 years old girl who received long-term ω3 FA poor total parental nutrition [18] . Isolated ω3-(or ω6-) deficiency does not necessarily cause augmented 20:3ω9, because of the 18:1ω9 119 desaturation suppressing effect of the remaining sufficient 18:2ω6 (or 18:3ω3 We established cut-off values, based on 97.5 percentiles, of RBC 20:3ω9 and 22:5ω6/22:6ω3 for assessment of biochemical EFAD and ω3-deficiency and investigated the added value of RBC 20:4ω6/22:6ω3 and 22:5ω6/22:4ω6 as parameters of ω3 status. The study population was composed of apparently healthy subgroups of different ages consuming either an LCP-containing omnivorous diet or a low-LCP diet (i.e. formula-fed infants and vegans). The cut-off values were validated by investigating their ability to detect EFAD and ω3-deficiency in a group of mostly malnourished Pakistani infants with known low EFA and/or ω3 status, in 3 patients with chronic fat-malabsorption of various causes, and in one patient with a peroxisomal disorder. The Pakistani data were also used for the comparison of the diagnostic sensitivities of RBC 22:5ω6/22:6ω3, 20:4ω6/22:6ω3 and 22:5ω6/22:4ω6 as indices of ω3-status.
Subjects and Methods

Study groups
The RBC FA data of this study are a collection of results from studies conducted by our research group during the past 10 years. The data derived from employment of the same pre-analytical and analytical methods for RBC FA analyses [29, 30] in a single laboratory. The selected study population was composed of two apparently healthy groups and two EFAD-suspected groups (Table 1) . Details regarding their dietary backgrounds can be obtained from the respective papers.
The apparently healthy subjects were either assigned to an omnivorous group or a group with low dietary LCP intake. The omnivorous group comprised 6 Dominica newborns (studied at two occasions), 32 human milk fed low-birth weight (LBW) Dutch infants (studied at three occasions) and 27 LBW Dutch babies who received formula with LCP (of which 1 was studied at one, 1 at two and 25 at three occasions), 31 Jerusalem infants, 33 Dutch 3.5-years old infants, 69 omnivorous Dutch adults and 7 Dominica mothers, totaling 326 data points. The low-dietary-LCP group comprised 81 LBW Dutch infants who received formula without LCP (studied at three occasions) and 12 Dutch adults consuming a vegan diet, totaling 255 data points. All LBW (≤ 2.50 kg) Dutch babies were born in the Groningen Martini Hospital, The Netherlands. They comprised a group of healthy, predominantly preterm, babies (gestational ages at birth 31-40 weeks; 66% ≤37 weeks) who participated in various studies on the effect of diet (i.e. breastmilk and formula with and without LCP) on LCP status. Their RBC FA were determined around postnatal days 11, 21 and 42 [21] [22] [23] . The 7 healthy Dominica mothers and 6 of their healthy babies (cord blood) were studied at delivery. These exclusively breast-fed infants were also investigated in the 20-22 days postnatal period [24] . The group of healthy breast-fed Jerusalem infants (ages 1 Ages are medians (range), Erythrocyte fatty acids are medians (2.5-97.5 percentiles). LBW, low-birth-weight; LCP, long chain polyunsaturated fatty acids; EFAD, essential fatty acid deficiency. 1, Human milk or formula+LCP fed infants; 2, formula (without LCP) fed infants; 3, data for n=11 (one outlier excluded). One Pakistani infant aged <0.2 years is not included in this Table. The cut-off value for EFAD was established by taking the mean of the 97. 6 months) were recruited from the 'Spafford mother and child health clinic' in EastJerusalem (unpublished data). The 3.5 years old healthy Dutch children participated in a study on the effect of perinatal exposure to PCB's and dioxins on neurological development [25] . The adult Dutch vegans and 15 of the adult omnivores participated in a study on the LCP status of the vegan diet [26] . The remaining 54 adult Dutch omnivores donated blood for the establishment of RBC FA reference values (unpublished results).
The EFAD and/or ω3-deficient groups were composed of 109 Pakistani infants and 4 pediatric patients. The, mostly malnourished, Pakistani infants (ages 2-60 months) were recruited from the Federal Government Service Hospital in Islamabad [27, 28] . They were classified as malnourished according to the Gomez classification, i.e. a weight below 75% of average for age, using the reference data from the United States National Center for Health Statistics. Of these children, 58.7% were breast-fed (70.3% malnourished, 29.7% not malnourished) and 38.5% were formula-fed (85.7% malnourished, 14.3% not malnourished). Nutritional status of 2.8% was unknown. Three pediatric patients suspected of EFAD and/or ω3-deficiency were diagnosed with abetalipoproteinemia (genetically confirmed), jenunal atresia (with apple peel syndrome) and biliary atresia. The other patient was diagnosed with a peroxisomal disorder, characterized by increased plasma 26:0/22:0 ratio, pipecolic acid concentration and phytanic acid.
Approval for the intervention studies with LBW babies was obtained from the medical ethical committee of the Groningen Martini Hospital. The study protocols of the 3.5 years old Dutch children and omnivorous and vegan Dutch adults were approved by the medical ethical committee of the Groningen University Hospital. All study protocols were in agreement with local ethical standards and the Helsinki declaration of 1975, as revised in 2000.
Blood sampling, processing and analyses
EDTA-anticoagulated blood samples were collected by venepuncture and immediately cooled in melting ice. The samples were centrifuged at 800 g for 10 min in a cooled centrifuge. Plasma and buffy coat were removed and the RBC washed three times with isotonic saline. The RBC were finally suspended to a hematocrit of about 50%. For the analysis of RBC FA, 200 µl of this suspension was transferred to a 15-ml Teflon-stoppered tube, containing 1 mg butylated hydroxytoluene (antioxidant) and 50.0 µg margaric acid (17:0; internal quantification standard). Preserved RBC samples were stored at -20 o C. The samples from Dominica, Jerusalem and Pakistan were transported to The Netherlands in dry ice. FA methyl esters were prepared by acid-catalyzed transmethylation. They were separated by gas chromatography on an apolar capillary column and detected with a flame ionization detector [29] . The RBC FA composition was calculated by assuming that equal peak areas give rise to equal weight amounts [30] . Data were expressed as mol% (FA composition) or mol/mol (FA ratios). The within-run and day-to-day precisions for 15 RBC FA have been described in detail [29] . They vary characteristically between 1.9-12.0% and 1.1-17.6%, dependent on FA abundance. The between-series precisions (in %) of some of the presently evaluated RBC FA amount to: 3. Figure 1 top), but became age-independent from 0.2 years. Since the P97.5 of the four subgroups aged ≥0.2 years seemed age-dependent (Table 1) , we decided to take the average of the Jerusalem infants and Dutch 3.5 years old infants to find a value of 0.46 mol% as the upper limit of EFA sufficiency for all subjects aged ≥0.2 years. The RBC 22:5ω6/22:6ω3 of the omnivorous group, Dominica newborns excluded, was agedependent (r= -0.668, p<0.0001, Figure 1 bottom). The RBC 22:5ω6/22:6ω3 of the omnivorous group was still age-dependent beyond the age of 0.2 years (r= -0.546, p<0.0001), but the P97.5 values of the Jerusalem infants and the Dutch omnivorous adults plus Dominica mothers proved remarkably similar (Table 1) . Despite the higher P97.5 of the Dutch 3.5 years old infants (see Discussion), we decided to take the average of the Jerusalem infants ≥0.2 years and the Dutch omnivorous adults plus Dominica mothers to find a value of 0.22 mol/mol as the upper limit of ω3-sufficiency for subjects aged ≥0.2 years. The RBC 22:5ω6/22:6ω3 of the low-dietary-LCP group was age-independent (Figure 1 bottom) and its 4 subgroups had similar P97.5 values (Table 1) . We therefore decided to average their P97.5 to find a value of 0.48 mol/mol as the upper limit of ω3-marginality for all ages.
Validation of RBC 20:3ω9 and 22:5ω6/22:6ω3 cut-off values
The 0.46 mol% RBC 20:3ω9 cut-off value for EFAD and the 0.22 and 0.48 mol/mol 22:5ω6/22:6ω3 cut-off values for ω3-marginality and ω3-deficiency were evaluated by investigating their influence on the classification of all subjects aged ≥0.2 years, i.e. 140 apparently healthy controls, 108 of the 109 malnourished Pakistani children and the four pediatric patients (Figure 2) . Because of the definition of the cut-off values at a P97.5, it is obvious that 2.5 percent of several apparently healthy subgroups were classified as EFAD, 
Discussion
Suspicion of low EFA or ω3 FA status may rather focus on clinical chemical tests than the presence of clinical symptoms. Early diagnosis is important, since it is increasingly recognized that subclinical micronutrient deficiencies may cause disease in the long run. We established cut-off values for RBC 20:3ω9 and 22:5ω6/22:6ω3 for establishment of biochemical EFAD, ω3-marginality and ω3-deficiency and investigated the added value of 20:4ω6/22:6ω3 and 22:5ω6/22:4ω6 as parameters of ω3 status. The cut-off values are based on the 97.5 percentiles of two major groups of apparently healthy subjects, who either consumed diets with LCP (breast-fed babies, babies receiving LCP-enriched formula, omnivorous infants and adults) or diets with very little LCP (babies receiving formula without LCP and vegans). Recruitment of healthy LBW, predominantly preterm, babies for establishment of cut-off values may be questioned. However, preterm and term babies have similar RBC LCP contents at birth and do not exhibit major differences in postnatal RBC LCP courses upon the same feeding regimen [6] . Newborns are known to have high 20:3ω9 and 22:5ω6/22:6ω3 [32] , and it was found that both the postnatal decline of 20:3ω9 and 22:5ω6/22:6ω3 in omnivorous subjects reached stable levels from the age of about 0.2 years (2.4 months). No 22:5ω6/22:6ω3 decrease seems to take place when the diet is virtually devoid of LCP, since infants who received formula without LCP and adult vegans had remarkably similar 22:5ω6/22:6ω3 ratios (Table 1) . We therefore defined two levels for ω3-status, i.e. one based on the RBC 22:5ω6/22:6ω3 P97.5 of omnivores (upper limit of ω3-sufficiency) and a second based on the P97.5 of formula-fed infants and vegans (upper limit ω3-marginality). The term 'marginality' was introduced to indicate that there is no evidence that the well-known low ω3-status of vegans [26] should be regarded as a state of ω3-deficiency. Data of the 3.5 years old Dutch infants were not used for the calculation of the upper limit of ω3-sufficiency. These children exhibited expected higher RBC 22:5ω6/22:6ω3 P97.5, compared with the Jerusalem infants ≥0.2 years and the Dutch omnivorous adults plus Dominica mothers (Table 1) . Fish intake of 1-4 years old Dutch children is known to be 70% lower than that of Dutch adults on a g/kcal/day basis [33] and many of them should probably be regarded to consume a vegan diet with regard to LCPω3 intake.
The finally selected cut-off values for 20:3ω9 (i.e. 0.46 mol%) and 22:5ω6/22:6ω3 (i.e. 0.22 and 0.48 mol/mol, Figure 1 ) cannot be easily validated, since there is no 'gold standard' for the diagnosis of EFAD or ω3-deficiency. We therefore decided to validate these outcomes in, mostly malnourished, North-Pakistani infants who are known to have very low intakes of vegetable oils and fish, causing high incidences of EFAD and ω3-deficiency with occasional symptoms consistent with these conditions [27, 34] . It was found that the encountered high percentages EFAD, ω3-marginality and ω3-deficiency are indeed consistent with their diets (Figure 2 ). Malnutrition is, however, by far more complex than EFAD alone, and we felt that current cut-off values required further confirmation in nonmalnutrition cases of EFAD and ω3-deficiency. It was found that the cut-off values enabled detection of EFAD and ω3-deficiency in patients with inherited disfunctional chylomicron assembly (abetalipoproteinemia) and congenital atresia of the jejunum and biliary ducts. The patient with the peroxisomal disorder had high 22:5ω6/22:6ω3, due to very low 22:6ω3. The low 22:6ω3 levels of patients with peroxisomal disorders are considered to derive from their low 24:6ω3 to 22:6ω3 retroconversion capacity, due to insufficient peroxisomal β-oxidation [35] . The value of the present cut-off values should however be investigated more closely in larger groups of patients with miscellaneous causes of chronic fat-malabsorption (e.g. cystic fibrosis, liver disease), increased EFA demand (cancer, trauma) and inborn errors that affect EFA-metabolism (such as the Zellweger's syndrome).
We used the same method for the calculation of cut-off values for RBC 20:4ω6/22:6ω3 and 22:5ω6/22:4ω6 as employed for 22:5ω6/22:6ω3. We subsequently compared the added value of the former two ratios to detect low ω3 status in the Pakistani children and the 4 pediatric patients. It was found that RBC 20:4ω6/22:6ω3 is age-dependent beyond the age of 0.2 years and that this ratio is also less sensitive for the detection of ω3-deficiency in the Pakistani children and pediatric patients, compared with 22:5ω6/22:6ω3. The RBC 22:5ω6/22:4ω6 ratio on its turn was age-independent from 0.2 years in omnivores, but proved less sensitive for the detection of low ω3-status compared with both the 22:5ω6/22:6ω3 and 20:4ω6/22:6ω3 ratios in the Pakistani children and the pediatric patients. Low sensitivity of the 22:5ω6/22:4ω6 ratio is disappointing, since analogous to 20:3ω9 for EFAD, this ratio may be regarded as a 'functional' marker [36] that detects competition between FA of the ω3 and ω6 series in favor of ω6. Moreover, the intakes of both 22:5ω6 and 22:4ω6 from the diet are probably very low, which leaves this ratio to be a closer reflection of enzymatic activity than ratios that contain potentially diet-derived LCP such as 22:6ω3 and 20:4ω6. The most plausible explanation for the discrepancy is that each of the presently investigated ratios reflects different aspects of ω3 status. Figure 1 bottom). Their deviation with time is due to the intake of 22:6ω3 from breastmilk or LCP-enriched formula, and the lack of dietary 22:6ω3 intake by feeding formula without LCP [6, 37] . There is evidence that enrichment of formula with 22:6ω3 improves early visual development, notably in prematures [37, 38] . This effect is transient, but has nevertheless been the basis to add 22:6ω3 to formula for prematures in many countries. Enrichment of formulas for term infants is also gaining increasing support. Whether 0.01-0.17 years (0.5-2.0 months) old infants with RBC 22:5ω6/22:6ω3 ratios in the about 0.43-0.48 mol/mol range should be classified as ω3-marginal, or even ω3-deficient, seems therefore rather a matter of opinion than a scientifically proven fact. It is in this context also interesting to point at the very low cord blood RBC 22:5ω6/22:6ω3 ratio of the breast-fed Dominica newborns (median 0.19; P97.5 0.26 mol/mol) ( Figure 1 bottom; Table 1 ), with similarly low 22:5ω6/22:6ω3 around postnatal day 21 (0.19; 0.27 mol/mol; data not shown in Table  1 ) and the even lower 22:5ω6/22:6ω3 of their mothers (0.09; 0.16 mol/mol; data not shown in Table 1 ). The Dominica mothers were known to have high fish intake and consequently high ω3-status, as also witnessed by their high breastmilk 22:6ω3 contents [24] . In contrast, the much higher RBC 22:5ω6/22:6ω3 of Dutch formula-and breast-fed infants and Dutch adults, is probably related to the typical North-European diet with low intake of fish and high dietary 18:2ω6/18:3ω3 ratio due to the predominant use of 18:2ω6-rich oils [39] . Intake of both fish and 18:3ω3 have been associated with lower risk of coronary artery disease in omnivores [40, 41] , and it seems therefore attractive to lower the 22:5ω6/22:6ω3 cut-off level for ω3-marginality (for omnivorous subjects) to that of the 97.5 percentile of the Dominica infants and their mothers. Such a cut-off value would classify the majority of the Western subjects as ω3-marginal and thereby illustrates the difficulty to define a border between ω3-sufficiency and marginality. It seems that any cut-off value for ω3 or 22:6ω3 status assessments may eventually have to be based on hard clinical evidence and not on a 97.5 percentile of an apparently healthy omnivorous population with inherently high risk of cardiovascular disease.
In conclusion, we calculated cut-off values for assessment of biochemical EFA status by measurement of RBC 20:3ω9, RBC 22:5ω6/22:6ω3 and RBC 22:5ω6/22:4ω6. The cut-off values are based on 97.5 percentiles of apparently healthy populations and apply for subjects aged ≥0.2 years (2.4 months). They amount to 0.46 mol% RBC 20:3ω9 for EFAD, 0.22 mol/mol RBC 22:5ω6/22:6ω3 for ω3-marginality, 0.48 mol/mol RBC 22:5ω6/22:6ω3 for ω3-deficiency and 0.33 mol/mol RBC 22:5ω6/22:4ω6 for low status of ω3 fatty acids up to 22:5ω3. It is important to realize that values beyond these cut-off values have not been validated on the basis of clinically detectable symptoms, but that they rather point at states of altered substrate competition (20:3ω9, 22:5ω6/22:4ω6) and altered LCPω6/LCPω3 balance (22:5ω6/22:6ω3), which might be consistent with subclinical deficiencies or imminent clinical deficiencies. Employment of present cut-off values indicated high prevalence of biochemical EFAD and ω3-deficiency in mostly malnourished North-Pakistani infants with very low intakes of vegetable oils and fish, in three patients with chronic fat-malabsorption and in one patient with a peroxisomal disorder. In view of lack of toxicity, increasing concern of the (long-term) consequences of low micronutrient status and relatively low costs, we suggest to use these cut-off values, for the decision of dietary supplement intervention until better concepts have emerged.
